Age-dependent accumulation of ubiquitinated 2′,3′-cyclic nucleotide 3′-phosphodiesterase in myelin lipid rafts

GLIA

Volumn 56, Issue 1, 2008, Pages 118-133

  Hinman, Jason D ^a   Chen, Ci Di ^a   Oh, Sun Young ^a   Hollander, William ^a   Abraham, Carmela R ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Biochemistry K620 ^*  (United States)

Author keywords

Aging; CNP; Lipid rafts; Monkey; Myelin; UbFC

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; MESSENGER RNA; MYELIN; TRITON X 100;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GENE OVEREXPRESSION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIPID RAFT; MALE; MASS SPECTROMETRY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHESUS MONKEY; TWO DIMENSIONAL ELECTROPHORESIS; UBIQUITINATION; WHITE MATTER;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AGING; ANIMALS; BLOTTING, WESTERN; CALPAIN; CAPILLARY ELECTROCHROMATOGRAPHY; CENTRIFUGATION, DENSITY GRADIENT; CERCOPITHECUS AETHIOPS; COS CELLS; DATA INTERPRETATION, STATISTICAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOPRECIPITATION; MACACA MULATTA; MASS SPECTROMETRY; MEMBRANE MICRODOMAINS; MYELIN SHEATH; NUCLEASE PROTECTION ASSAYS; OLIGODENDROGLIA; PLASMIDS; RNA, MESSENGER; UBIQUITIN;

EID: 36448941439     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20595     Document Type: Article

References (75)

1. Agrawal HC, Sprinkle TJ, Agrawal D. 1990. 2′,3′-cyclic nucleotide-3′-phosphodiesterase in the central nervous system is fatty-acylated by thioester linkage. J Biol Chem 265:11849-11853.
2. Akaishi T, Shiomi T, Sawada H, Yokosawa H. 1996. Purification and properties of the 26S proteasome from the rat brain: Evidence for its degradation of myelin basic protein in a ubiquitin-dependent manner. Brain Res 722:139-144.
3. Bifulco M, Laezza C, Aloj SM, Garbi C. 1993. Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells. J Cell Physiol 155:340-348.
4. Bifulco M, Laezza C, Stingo S, Wolff J. 2002. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: A membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci USA 99:1807-1812.
5. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. 2004. Molecular pathways to neurodegeneration. Nat Med 10 Suppl:S2-S9.
6. Braun P, Lee J, Gravel M. 2004. 2′,3′-cyclic nucleotide 3′-phosphodiesterase: Structure, biology, and function. In: Lazzarini RA, editor. Myelin biology and disorders. San Diego, London: Elsevier. pp 499-522.
7. Braun PE, De Angelis D, Shtybel WW, Bernier L. 1991. Isoprenoid modification permits 2′,3′-cyclic nucleotide 3′- phosphodiesterase to bind to membranes. J Neurosci Res 30:540-544.
8. Braun PE, Sandillon F, Edwards A, Matthieu JM, Privat A. 1988. Immunocytochemical localization by electron microscopy of 2′3′- cyclic nucleotide 3′-phosphodiesterase in developing oligodendrocytes of normal and mutant brain. J Neurosci 8:3057-3066.
9. Buntinx M, Vanderlocht J, Hellings N, Vandenabeele F, Lambrichts I, Raus J, Ameloot M, Stinissen P, Steels P. 2003. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expression. J Neurocytol 32:25-38.
10. De Angelis DA, Braun PE. 1996. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase binds to actin-based cytoskeletal elements in an isoprenylation-independent manner. J Neurochem 67:943-951.
11. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen SH. 1990. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 63:87-99.
12. Dyer CA, Benjamins JA. 1988. Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J Neurosci 8:4307-4318.
13. Dyer CA, Benjamins JA. 1989. Organization of oligodendroglial membrane sheets. I: Association of myelin basic protein and 2′,3′-cyclic nucleotide 3′-phosphohydrolase with cytoskeleton. J Neurosci Res 24:201-211.
14. Dyer CA, Matthieu JM. 1994. Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J Neurochem 62:777-787.
15. Dyer CA, Philibotte TM, Billings-Gagliardi S, Wolf MK. 1995. Cytoskeleton in myelin-basic-protein-deficient shiverer oligodendrocytes. Dev Neurosci 17:53-62.
16. Endres M, Laufs U. 2004. Effects of statins on endothelium and signaling mechanisms. Stroke 35(11, Suppl 1):2708-2711.
17. Fang D, Kerppola TK. 2004. Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. Proc Natl Acad Sci USA 101:14782-14787.
18. Ferrer I, Pumarola M, Rivera R, Zujar MJ, Cruz-Sanchez F, Vidal A. 1993. Primary central white matter degeneration in old dogs. Acta Neuropathol (Berl) 86:172-175.
19. Flick K, Ouni I, Wohlschlegel JA, Capati C, McDonald WH, Yates JR, Kaiser P. 2004. Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain. Nat Cell Biol 6:634-641.
20. Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L. 2006. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis 22:153-164.
21. Gandy S. 2005. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 115:1121-1129.
22. Goldberg AL. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426:895-899.
23. Gravel M, Peterson J, Yong VW, Kottis V, Trapp B, Braun PE. 1996. Overexpression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci 7:453-466.
24. Grune T, Jung T, Merker K, Davies KJ. 2004. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and "aggresomes" during oxidative stress, aging, and disease. Int J Biochem Cell Biol 36:2519-2530.
25. Herndon JG, Lacreuse A. 2002. The rhesus monkey as a heuristic resource in cognitive aging research. In: Erwin JM,Hof PR, editors. Aging in nonhuman primates. Basel: Karger. pp 178-195.
26. Hill CM, Libich DS, Harauz G. 2005. Assembly of tubulin by classic myelin basic protein isoforms and regulation by post-translational modification. Biochemistry 44:16672-16683.
27. Hinman JD, Abraham CR. What's behind the decline? - The role of white matter in brain aging. Neurochem Res, in press.
28. Hinman JD, Duce JA, Siman RA, Hollander W, Abraham CR. 2004. Activation of calpain-1 in myelin and microglia in the white matter of the aged rhesus monkey. J Neurochem 89:430-441.
29. Hinman JD, Peters A, Cabral H, Rosene DL, Hollander W, Rasband MN, Abraham CR. 2006. Age-related molecular reorganization at the node of Ranvier. J Comp Neurol 495:351-362.
30. Hofmann A, Grella M, Botos I, Filipowicz W, Wlodawer A. 2002. Crystal structures of the semireduced and inhibitor-bound forms of cyclic nucleotide phosphodiesterase from Arabidopsis thaliana. J Biol Chem 277:1419-1425.
31. Hu CD, Chinenov Y, Kerppola TK. 2002. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 9:789-798.
32. Hu CD, Kerppola TK. 2003. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol 21:539-545.
33. Kaiser P, Wohlschlegel J. 2005. Identification of ubiquitination sites and determination of ubiquitin-chain architectures by mass spectrometry. Methods Enzymol 399:266-277.
34. Kim T, Pfeiffer SE. 1999. Myelin glycosphingolipid/cholesterol-enriched microdomains selectively sequester the non-compact myelin proteins CNP and MOG. J Neurocytol 28:281-293.
35. Kurihara T, Tsukada Y. 1967. The regional and subcellular distribution of 2′,3′-cyclic nucleotide 3′-phosphohydrolase in the central nervous system. J Neurochem 14:1167-1174.
36. Laezza C, Wolff J, Bifulco M. 1997. Identification of a 48-kDa prenylated protein that associates with microtubules as 2′,3′-cyclic nucleotide 3′-phosphodiesterase in FRTL-5 cells. FEBS Lett 413:260-264.
37. Lafont F, Simons K. 2001. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc Natl Acad Sci USA 98:3180-3184.
38. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
39. Layfield R, Lowe J, Bedford L. 2005. The ubiquitin-proteasome system and neurodegenerative disorders. Essays Biochem 41:157-171.
40. Lee J, Gravel M, Gao E, O'Neill RC, Braun PE. 2001. Identification of essential residues in 2′,3′-cyclic nucleotide 3′- phosphodiesterase. Chemical modification and site-directed mutagenesis to investigate the role of cysteine and histidine residues in enzymatic activity. J Biol Chem 276:14804-14813.
41. Lee J, Gravel M, Zhang R, Thibault P, Braun PE. 2005. Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol 170:661-673.
42. Lees MB, Sapirstein VS, Reiss DS, Kolodny EH. 1980. Carbonic anhydrase and 2′,3′ cyclic nucleotide 3′-phosphohydrolase activity in normal human brain and in demyelinating diseases. Neurology 30(7, Part 1):719-725.
43. Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C. 2003. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18:655-664.
44. Lintner RN, Dyer CA. 2000. Redistribution of cholesterol in oligodendrocyte membrane sheets after activation of distinct signal transduction pathways. J Neurosci Res 60:437-449.
45. Makris N, Papadimitriou GM, van der Kouwe A, Kennedy DN, Hodge SM, Dale AM, Benner T, Wald LL, Wu O, Tuch DS, Caviness VS, Moore TL, Killiany RJ, Moss MB, Rosene DL. 2007. Frontal connections and cognitive changes in normal aging rhesus monkeys: A DTI study. Neurobiol Aging 28:1556-1567.
46. Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE. 2003. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci 23:5461-5471.
47. McLaurin J, Trudel GC, Shaw IT, Antel JP, Cashman NR. 1995. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol 26:283-293.
48. Migheli A, Attanasio A, Pezzulo T, Gullotta F, Giordana MT, Schiffer D. 1992. Age-related ubiquitin deposits in dystrophic neurites: An immunoelectron microscopic study. Neuropathol Appl Neurobiol 18:3-11.
49. Moore DJ, West AB, Dawson VL, Dawson TM. 2005. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57-87.
50. Norton WT, Poduslo SE. 1973. Myelination in rat brain: Method of myelin isolation. J Neurochem 21:749-757.
51. Olafson RW, Drummond GI, Lee JF. 1969. Studies on 2′,3′- cyclic nucleotide-3′-phosphohydrolase from brain. Can J Biochem 47:961-966.
52. Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J, Finley D, Gygi SP. 2003. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 21:921-926.
53. Persson H, Corneliuson O. 1989. Degradation products of myelin proteins in a light CNS subcellular fraction. Neurochem Res 14:1177-1180.
54. Peters A. 1996. Age-related changes in oligodendrocytes in monkey cerebral cortex. J Comp Neurol 371:153-163.
55. Peters A. 2002a. The effects of normal aging on myelin and nerve fibers: A review. J Neurocytol 31:581-593.
56. Peters A. 2002b. Structural changes in the normally aging cerebral cortex of primates. Prog Brain Res 136:455-465.
57. Peters A, Morrison JH, Rosene DL, Hyman BT. 1998a. Feature article: Are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex 8:295-300.
58. Peters A, Moss MB, Sethares C. 2001. The effects of aging on layer 1 of primary visual cortex in the rhesus monkey. Cereb Cortex 11:93-103.
59. Peters A, Sethares C. 2002a. Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. J Comp Neurol 442:277-291.
60. Peters A, Sethares C. 2002b. The effects of age on the cells in layer 1 of primate cerebral cortex. Cereb Cortex 12:27-36.
61. Peters A, Sethares C, Moss MB. 1998b. The effects of aging on layer 1 in area 46 of prefrontal cortex in the rhesus monkey. Cereb Cortex 8:671-684.
62. Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave KA, Bansal R. 2005. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50:86-90.
63. Sandell JH, Peters A. 2003. Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey. J Comp Neurol 466: 14-30.
64. Sloane JA, Hinman JD, Lubonia M, Hollander W, Abraham CR. 2003. Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the rhesus monkey. J Neurochem 84:157-168.
65. Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR. 1999. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging 20:395-405.
66. Sloane JA, Hollander W, Rosene DL, Moss MB, Kemper T, Abraham CR. 2000. Astrocytic hypertrophy and altered GFAP degradation with age in subcortical white matter of the rhesus monkey. Brain Res 862:1-10.
67. Sprinkle TJ. 1989. 2′,3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4:235-301.
68. Taylor CM, Marta CB, Bansal R, Pfeiffer SE. 2004a. The transport, assembly, and function of myelin lipids. In: Lazzarini RA, editor. Myelin biology and disorders. San Diego: Elsevier. pp 57-88.
69. Taylor CM, Marta CB, Claycomb RJ, Han DK, Rasband MN, Coetzee T, Pfeiffer SE. 2004b. Proteomic mapping provides powerful insights into functional myelin biology. Proc Natl Acad Sci USA 101:4643-4648.
70. Tian QB, Okano A, Nakayama K, Miyazawa S, Endo S, Suzuki T. 2003. A novel ubiquitin-specific protease, synUSP, is localized at the postsynaptic density and post-synaptic lipid raft. J Neurochem 87:665-375.
71. Trapp BD, Bernier L, Andrews SB, Colman DR. 1988. Cellular and subcellular distribution of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and its mRNA in the rat central nervous system. J Neurochem 51:859-868.
72. Tseng BP, Kitazawa M, LaFerla FM. 2004. Amyloid beta-peptide: The inside story. Curr Alzheimer Res 1:231-239.
73. Ward WF. 2002. Protein degradation in the aging organism. Prog Mol Subcell Biol 29:35-42.
74. Yin X, Peterson J, Gravel M, Braun PE, Trapp BD. 1997. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J Neurosci Res 50:238-247.
75. Zhang K, Kaufman RJ. 2006. The unfolded protein response. A stress signaling pathway critical for health and disease. Neurology 66(2 Suppl 1):S102-109. Review.